LONG-TERM SAFETY AND EFFICACY OF LISDEXAMFETAMINE DIMESYLATE BY AGE SUBGROUP IN CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

被引：0
|
作者：
Coghill, D. [1 ]
Hernandez Otero, I. [2 ]
Nagy, P. [3 ,4 ]
Soutullo, C. A. [5 ]
Zuddas, A. [6 ]
Geibel, B. [7 ]
Naser, N. [8 ]
Yan, B. [7 ]
Banaschewski, T. [9 ]
机构：
[1] Univ Dundee, Div Neurosci, Dundee, Scotland
[2] Maritime Hosp, Univ Hosp Virgen de la Victoria, Unit Child & Adolescent Mental Hlth USMIJ, Malaga, Spain
[3] Vadaskert Child & Adolescent Psychiat Hosp, Budapest, Hungary
[4] Outpatient Clin, Budapest, Hungary
[5] Univ Navarra Clin, Dept Psychiat & Med Psychol, Child & Adolescent Psychiat Unit, Pamplona, Spain
[6] Univ Cagliari, Dept Biomed Sci, Sect Neurosci & Clin Pharmacol, Cagliari, Italy
[7] Shire, Wayne, PA USA
[8] Shire, Sydney, NSW, Australia
[9] Heidelberg Univ, Med Fac Mannheim, Dept Child & Adolescent Psychiat & Psychotherapy, Cent Inst Mental Hlth, Mannheim, Germany
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2016年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：162 / 162
页数：1
相关论文
共 50 条
  • [41] Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents with Attention-Deficit/Hyperactivity Disorder
    Childress, Ann C.
    Cutler, Andrew J.
    Saylor, Keith
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Findling, Robert L.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (04) : 210 - 217
  • [42] The Efficacy and Safety Profile of Lisdexamfetamine Dimesylate, a Prodrug of d-Amphetamine, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adults
    Najib, Jadwiga
    CLINICAL THERAPEUTICS, 2009, 31 (01) : 142 - 176
  • [43] Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder
    Najib, Jadwiga
    ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2012, 3 : 51 - 66
  • [44] POST HOC COMPARISON OF THE EFFICACY OF LISDEXAMFETAMINE DIMESYLATE AND OSMOTIC-RELEASE ORAL SYSTEM METHYLPHENIDATE IN CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER
    Sorooshian, Shaw
    Banaschewski, Tobias
    Lecendreux, Michel
    Soutullo, Cesar
    Johnson, Mats
    Zuddas, Alessandro
    Anderson, Colleen
    Civil, Richard
    Higgins, Nicholas
    Bloomfield, Ralph
    Squires, Liza
    Coghill, David
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2013, 47 (S1): : 89 - 90
  • [45] Long-term cardiovascular safety of psychostimulants in children with attention deficit hyperactivity disorder
    Conzelmann, Annette
    Mueller, Stefan
    Jans, Thomas
    Trott, Goetz-Erik
    Keil, Thomas
    Gerlach, Manfred
    Renner, Tobias J.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2019, 23 (02) : 157 - 159
  • [46] Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: A post hoc analysis
    Jain R.
    Babcock T.
    Burtea T.
    Dirks B.
    Adeyi B.
    Scheckner B.
    Lasser R.
    Child and Adolescent Psychiatry and Mental Health, 5 (1)
  • [47] Effect Size of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder
    Wigal, Timothy
    Brams, Matthew
    Gasior, Maria
    Gao, Joseph
    Giblin, John
    POSTGRADUATE MEDICINE, 2011, 123 (02) : 169 - 176
  • [48] Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder
    Lenard A Adler
    David Goodman
    Richard Weisler
    Mohamed Hamdani
    Thomas Roth
    Behavioral and Brain Functions, 5
  • [49] Efficacy and safety of lisdexamfetamine dimesylate [LDX; NRP104] in children aged 6 to 12 years with attention-deficit/hyperactivity disorder
    Biederman, Joseph
    Mandler, Hilary
    Krishnan, Suma
    Findling, Robert L.
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2006, 27 (05): : 443 - 443
  • [50] Lisdexamfetamine Dimesylate A New Therapeutic Option for Attention-Deficit Hyperactivity Disorder
    Steer, Christopher
    Froelich, Jan
    Soutullo, Cesar A.
    Johnson, Mats
    Shaw, Monica
    CNS DRUGS, 2012, 26 (08) : 691 - 705
12345